BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 29364302)

  • 1. Effects of a combined intervention with a lentil protein hydrolysate and a mixed training protocol on the lipid metabolism and hepatic markers of NAFLD in Zucker rats.
    Martínez R; Kapravelou G; Donaire A; Lopez-Chaves C; Arrebola F; Galisteo M; Cantarero S; Aranda P; Porres JM; López-Jurado M
    Food Funct; 2018 Feb; 9(2):830-850. PubMed ID: 29364302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aerobic interval exercise improves parameters of nonalcoholic fatty liver disease (NAFLD) and other alterations of metabolic syndrome in obese Zucker rats.
    Kapravelou G; Martínez R; Andrade AM; Nebot E; Camiletti-Moirón D; Aparicio VA; Lopez-Jurado M; Aranda P; Arrebola F; Fernandez-Segura E; Bermano G; Goua M; Galisteo M; Porres JM
    Appl Physiol Nutr Metab; 2015 Dec; 40(12):1242-52. PubMed ID: 26509584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Combined Intervention with Germinated Vigna radiata and Aerobic Interval Training Protocol Is an Effective Strategy for the Treatment of Non-Alcoholic Fatty Liver Disease (NAFLD) and Other Alterations Related to the Metabolic Syndrome in Zucker Rats.
    Kapravelou G; Martínez R; Nebot E; López-Jurado M; Aranda P; Arrebola F; Cantarero S; Galisteo M; Porres JM
    Nutrients; 2017 Jul; 9(7):. PubMed ID: 28753963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment with a novel oleic-acid-dihydroxyamphetamine conjugation ameliorates non-alcoholic fatty liver disease in obese Zucker rats.
    Decara JM; Pavón FJ; Suárez J; Romero-Cuevas M; Baixeras E; Vázquez M; Rivera P; Gavito AL; Almeida B; Joglar J; de la Torre R; Rodríguez de Fonseca F; Serrano A
    Dis Model Mech; 2015 Oct; 8(10):1213-25. PubMed ID: 26438694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The combined treatment with lentil protein hydrolysate and a mixed training protocol is an efficient lifestyle intervention to manage cardiovascular and renal alterations in obese Zucker rats.
    Porres JM; Constantino J; Kapravelou G; Lopez-Chaves C; Galisteo M; Aranda P; López-Jurado M; Martínez R
    Eur J Nutr; 2020 Dec; 59(8):3473-3490. PubMed ID: 32030473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel effects of the cannabinoid inverse agonist AM 251 on parameters related to metabolic syndrome in obese Zucker rats.
    Merroun I; Sánchez-González C; Martínez R; López-Chaves C; Porres JM; Aranda P; Llopis J; Galisteo M; Zarzuelo A; Errami M; López-Jurado M
    Metabolism; 2013 Nov; 62(11):1641-50. PubMed ID: 23932644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochanin A improves hepatic steatosis and insulin resistance by regulating the hepatic lipid and glucose metabolic pathways in diet-induced obese mice.
    Park HS; Hur HJ; Kim SH; Park SJ; Hong MJ; Sung MJ; Kwon DY; Kim MS
    Mol Nutr Food Res; 2016 Sep; 60(9):1944-55. PubMed ID: 27145114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Green tea polyphenols ameliorate non-alcoholic fatty liver disease through upregulating AMPK activation in high fat fed Zucker fatty rats.
    Tan Y; Kim J; Cheng J; Ong M; Lao WG; Jin XL; Lin YG; Xiao L; Zhu XQ; Qu XQ
    World J Gastroenterol; 2017 Jun; 23(21):3805-3814. PubMed ID: 28638220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of interval aerobic training combined with strength exercise on body composition, glycaemic and lipid profile and aerobic capacity of obese rats.
    Coll-Risco I; Aparicio VA; Nebot E; Camiletti-Moirón D; Martínez R; Kapravelou G; López-Jurado M; Porres JM; Aranda P
    J Sports Sci; 2016 Aug; 34(15):1452-60. PubMed ID: 26634322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sake lees extract improves hepatic lipid accumulation in high fat diet-fed mice.
    Kubo H; Hoshi M; Matsumoto T; Irie M; Oura S; Tsutsumi H; Hata Y; Yamamoto Y; Saito K
    Lipids Health Dis; 2017 Jun; 16(1):106. PubMed ID: 28578672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effects of liraglutide 3 mg vs structured lifestyle modification on body weight, liver fat and liver function in obese patients with non-alcoholic fatty liver disease: A pilot randomized trial.
    Khoo J; Hsiang J; Taneja R; Law NM; Ang TL
    Diabetes Obes Metab; 2017 Dec; 19(12):1814-1817. PubMed ID: 28503750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resveratrol attenuates steatosis in obese Zucker rats by decreasing fatty acid availability and reducing oxidative stress.
    Gómez-Zorita S; Fernández-Quintela A; Macarulla MT; Aguirre L; Hijona E; Bujanda L; Milagro F; Martínez JA; Portillo MP
    Br J Nutr; 2012 Jan; 107(2):202-10. PubMed ID: 21733326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aerobic training improves NAFLD markers and insulin resistance through AMPK-PPAR-α signaling in obese mice.
    Diniz TA; de Lima Junior EA; Teixeira AA; Biondo LA; da Rocha LAF; Valadão IC; Silveira LS; Cabral-Santos C; de Souza CO; Rosa Neto JC
    Life Sci; 2021 Feb; 266():118868. PubMed ID: 33310034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of Electroacupunctrue Combined with Dietary Control on Peroxisome Proliferator-activa- ted Receptor-α, and Liver Fatty Acid-binding Protein Levels in Non-alcoholic Fatty Liver Disease Rats].
    Zhang Y; Tang CL; Tian Y; Yuan HZ; Yang H; Tang NZ; Gao RQ; Cao J
    Zhen Ci Yan Jiu; 2015 Oct; 40(5):345-51. PubMed ID: 26669188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the new thiazolidine derivative LPSF/GQ-02 on hepatic lipid metabolism pathways in non-alcoholic fatty liver disease (NAFLD).
    Araújo S; Soares E Silva A; Gomes F; Ribeiro E; Oliveira W; Oliveira A; Lima I; Lima MDC; Pitta I; Peixoto C
    Eur J Pharmacol; 2016 Oct; 788():306-314. PubMed ID: 27349145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary walnut oil modulates liver steatosis in the obese Zucker rat.
    Fink A; Rüfer CE; Le Grandois J; Roth A; Aoude-Werner D; Marchioni E; Bub A; Barth SW
    Eur J Nutr; 2014; 53(2):645-60. PubMed ID: 23942585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Singular effects of PPAR agonists on nonalcoholic fatty liver disease of diet-induced obese mice.
    Barbosa-da-Silva S; Souza-Mello V; Magliano DC; Marinho Tde S; Aguila MB; Mandarim-de-Lacerda CA
    Life Sci; 2015 Apr; 127():73-81. PubMed ID: 25748419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sweroside ameliorates NAFLD in high-fat diet induced obese mice through the regulation of lipid metabolism and inflammatory response.
    Yang Q; Shu F; Gong J; Ding P; Cheng R; Li J; Tong R; Ding L; Sun H; Huang W; Wang Z; Yang L
    J Ethnopharmacol; 2020 Jun; 255():112556. PubMed ID: 31926984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A combined healthy strategy for successful weight loss, weight maintenance and improvement of hepatic lipid metabolism.
    Martínez R; López-Trinidad LM; Kapravelou G; Arrebola F; Galisteo M; Aranda P; Porres JM; López-Jurado M
    J Nutr Biochem; 2020 Nov; 85():108456. PubMed ID: 32810797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. α-Linolenic acid supplementation and exercise training reveal independent and additive responses on hepatic lipid accumulation in obese rats.
    Miotto PM; Horbatuk M; Proudfoot R; Matravadia S; Bakovic M; Chabowski A; Holloway GP
    Am J Physiol Endocrinol Metab; 2017 Jun; 312(6):E461-E470. PubMed ID: 28270444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.